Navigation Links
PediaVision to Conduct Spot Demonstrations During American Academy of Ophthalmology Annual Meeting
Date:10/18/2011

LAKE MARY, Fla., Oct. 18, 2011 /PRNewswire/ --WHO:David Melnik, President & CEO of PediaVisionJeff Mortensen, Vice President of PediaVisionWHAT:Will be conducting demonstrations of Spot, a revolutionary new vision screening device, which identifies vision problems in less than one second.WHEN:Wednesday, October 19, Thursday, October 20, Friday October 21 WHY:Spot is a new breakthrough vision screening device that will help children across America.  Spot has an incredibly quick capture time of less than one second which makes screening equally efficient in a physician's office or large-scale public screening. Spot is easily used by anyone when screening children from 6 months through adults.  URGENCY:

There is an on-going and urgent need for Spot.  The U. S. Centers for Disease Control and Prevention (CDC) state that vision disability is the single most prevalent disabling condition among children. Approximately 80 percent(1) of what children learn in their early school years is visual, so if they can't see a teacher's writing on the blackboard, they will struggle.(1)  American Optometric Association
'/>"/>

SOURCE PediaVision
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. PediaVision Announces Record New Orders for Revolutionary New Vision Screening Device, Spot
2. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
3. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Maine Natural Health Company Conducts Dental Clinical Trial
8. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
9. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
10. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
11. Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2017)... , Aug. 3, 2017  Opioid addiction and other ... up healthcare costs and threatening outcomes, were problems taken ... and IVD industry that support them, met this week. ... researcher said that drugs of abuse, procalcitonin and acute ... at the organization,s 69th meeting in San ...
(Date:8/1/2017)... --  CerSci Therapeutics , a non-opioid drug development firm ... received notice from the National Institute on Drug Abuse ... it has been awarded a Direct-to-Phase II Small Business ... with an additional $1,000,000 to follow in 2018. These ... their lead non-opioid drug candidate CT-044 to the Food ...
(Date:7/28/2017)... --EnvoyHealth, a Diplomat company, has partnered with Compliance Meds ... a technology designed to improve patient medication adherence. ... solutions and services that help track and improve patients, ... LITE offers medication monitoring and control for patients and ... Records date and time of bottle ...
Breaking Medicine Technology:
(Date:8/17/2017)... , ... August 17, 2017 , ... When Amy ... stretcher side nurse, she took with her a dream to make nursing education more ... Specifically, ensuring communication skills were integrated into healthcare provider education. , ...
(Date:8/17/2017)... ... August 17, 2017 , ... Brookfield, ... for healthcare, hospitality and education, is celebrating its 30th year in business this ... begun at manufacturing companies Square D, Allis Chalmers and Johnson Controls. Following his ...
(Date:8/17/2017)... ... 2017 , ... Aeroflow Healthcare today announced its placement on ... private companies. Inc. magazine ranked Aeroflow Healthcare #2450 on its annual list, showcasing ... Inc. 5000 represents the most comprehensive study of American entrepreneurial enterprises based on ...
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article on ... plastic surgery, largely influenced by the growing popularity of “pretty boys” in both K-Pop ... that standards of male appearance are changing not only in the Asian nation, where ...
(Date:8/17/2017)... ... August 17, 2017 , ... Pot Valet is a leading provider of premium ... in the state, and soon, every state in the country, the company offers patients ... cannabis dispensary altogether. , According to Pot Valet, all California patients have ...
Breaking Medicine News(10 mins):